Fresenius Kabi

Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement

Initiative Focused on Scaling Advanced Cell and Gene Therapy to Enhance Patient Access 14 January 2026 — Illinois, US — Fresenius Kabi, an operating company of Fresenius, and TQ Therapeutics, announced today they have entered into a strategic-development agreement under which Fresenius Kabi has an exclusive license to develop, manufacture, and distribute products that incorporate TQ…
Three Corporate Drive Lake Zurich, Illinois 60047

(847) 550-2300